Detail
| LncRNA Name | CASC9.5 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 M8140/3 |
| Methods | qPCR, Western blot, in vitro knockdown, RNAi, RIP |
| Sample | lung adenocarcinoma tissue, lung adenocarcinomar cell lines (A549 and SPC-A1) |
| Expression Pattern | up-regulated |
| Function Description | CASC9.5 expression levels were significantly higher in lung cancer tissues and cells compared with normal lung tissues.CASC9.5 promoted lung adenocarcinoma cell proliferation and metabolism by regulating the expression levels of cyclin D1, E-cadherin, N-cadherin and B-catenin. |
| Pubmed ID | 29311567 |
| Year | 2018 |
| Title | Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. |
| External Links |
| Links for CASC9.5 | GenBank HGNC lncrnadb Noncode |
| Links for lung adenocarcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.